Kevin Lundquist's most recent trade in Outlook Therapeutics Inc was a trade of 500,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Outlook Therapeutics Inc | Kevin Lundquist | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2026 | 500,000 | 500,000 | - | - | Employee Stock Option (Right to Buy) |